Search Results - "Schewe DM"

Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL.

Authors: Pinkle D Cornils M Dietterle A et al.

Source: HemaSphere [Hemasphere] 2026 Jun 17; Vol. 10 (6), pp. e70407. Date of Electronic Publication: 2026 Jun 17 (Print Publication: 2026).

Publication Type: Letter

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Safety of Telemedicine Follow-Up Visits in Children With Cancer Undergoing Intensive Chemotherapy: Results From the Randomized KULT-SH Trial.

Authors: Schewe DM Rademacher A Kattner P et al.

Source: JCO oncology practice [JCO Oncol Pract] 2026 May 27, pp. OP2501303. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.

Authors: Lustig M Kowol M Hartmann AM et al.

Source: Blood neoplasia [Blood Neoplasia] 2026 May 05; Vol. 3 (3), pp. 100242. Date of Electronic Publication: 2026 May 05 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.

Authors: Küchler S Brilloff S Schäfer S et al.

Source: Cell death discovery [Cell Death Discov] 2025 Oct 20; Vol. 11 (1), pp. 470. Date of Electronic Publication: 2025 Oct 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemia.

Authors: Schäfer S Rahimian E Schmitz-Hübsch L et al.

Source: Cell reports [Cell Rep] 2026 Mar 24; Vol. 45 (3), pp. 117010. Date of Electronic Publication: 2026 Feb 18.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.

Authors: Kolodziejczak AS Guerrini-Rousseau L Planchon JM et al.

Source: Neuro-oncology [Neuro Oncol] 2023 Dec 08; Vol. 25 (12), pp. 2273-2286.

Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML.

Authors: Rahimian E Koochak M Traikov S et al.

Source: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2025 Jul; Vol. 81, pp. 101242. Date of Electronic Publication: 2025 Mar 28.

Publication Type: Journal Article

Journal Info: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9815369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2084 (Electronic) Linking ISSN: 13687646 NLM ISO Abbreviation: Drug Resist Updat Subsets: MEDLINE

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.

Authors: Zeller T Münnich IA Windisch R et al.

Source: Frontiers in immunology [Front Immunol] 2023 Sep 13; Vol. 14, pp. 1240275. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Two is better than one: dual targeting of WDR5 in T-ALL.

Authors: Wurm AA Schewe DM

Source: Blood [Blood] 2025 Mar 27; Vol. 145 (13), pp. 1339-1341.

Publication Type: Editorial; Comment

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE; In Process

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia.

Authors: Stanulla M Schewe DM Bornhauser B et al.

Source: Annals of hematology [Ann Hematol] 2023 Mar; Vol. 102 (3), pp. 669-672. Date of Electronic Publication: 2023 Jan 18.

Publication Type: Letter

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody.

Authors: Gehlert CL Rahmati P Boje AS et al.

Source: Frontiers in immunology [Front Immunol] 2022 Aug 31; Vol. 13, pp. 957874. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.

Authors: Baumann N Arndt C Petersen J et al.

Source: Frontiers in immunology [Front Immunol] 2022 Aug 16; Vol. 13, pp. 949140. Date of Electronic Publication: 2022 Aug 16 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL.

Authors: Gebing P Loizou S Hänsch S et al.

Source: Blood advances [Blood Adv] 2024 Oct 08; Vol. 8 (19), pp. 4997-5011.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.

Authors: Carlet M Völse K Vergalli J et al.

Source: Nature communications [Nat Commun] 2021 Sep 27; Vol. 12 (1), pp. 5655. Date of Electronic Publication: 2021 Sep 27.

Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.

Authors: Baumann N Rösner T Jansen JHM et al.

Source: Cancer science [Cancer Sci] 2021 Aug; Vol. 112 (8), pp. 3029-3040. Date of Electronic Publication: 2021 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.

Authors: Lenk L Baccelli I Laqua A et al.

Source: Blood [Blood] 2024 Jun 27; Vol. 143 (26), pp. 2735-2748.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.

Authors: Schewe DM Vogiatzi F Münnich IA et al.

Source: HemaSphere [Hemasphere] 2024 Feb 22; Vol. 8 (2), pp. e48. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL.

Authors: Antić Ž van Bömmel A Riege K et al.

Source: Leukemia [Leukemia] 2023 Dec; Vol. 37 (12), pp. 2522-2525. Date of Electronic Publication: 2023 Oct 16.

Publication Type: Letter; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

AP-1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL.

Authors: Spory L Zimmermann J Vossen-Gajcy M et al.

Source: HemaSphere [Hemasphere] 2023 Sep 01; Vol. 7 (9), pp. e945. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Abdelrasoul H Vadakumchery A Werner M et al.

Source: Nature communications [Nat Commun] 2020 Jun 24; Vol. 11 (1), pp. 3194. Date of Electronic Publication: 2020 Jun 24.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE